Goldenwell Biotech (Goldenwell Biotech) Other Long-Term Liabilities : $0.14 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Goldenwell Biotech Other Long-Term Liabilities?

Goldenwell Biotech's other long-term liabilities for the quarter that ended in Mar. 2024 was $0.14 Mil.

Goldenwell Biotech's quarterly other long-term liabilities increased from Sep. 2023 ($0.08 Mil) to Dec. 2023 ($0.14 Mil) and increased from Dec. 2023 ($0.14 Mil) to Mar. 2024 ($0.14 Mil).

Goldenwell Biotech's annual other long-term liabilities increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.02 Mil) and increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.14 Mil).

Goldenwell Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Goldenwell Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goldenwell Biotech Other Long-Term Liabilities Chart

Goldenwell Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Goldenwell Biotech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial										-	-	-	-	-

Goldenwell Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Goldenwell Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Goldenwell Biotech (Goldenwell Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Goldenwell Biotech Inc (OTCPK:GWLL) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2071 Midway Drive, Twinsburg, OH, USA, 44087

Website

https://www.goldenwellbiotech.com

Goldenwell Biotech Inc is engaged in the research and development, production and sales of health care and supplements products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.

Executives

Li Yang	director, 10 percent owner, officer: Treasurer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Hua Xie	director, officer: Secretary	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Shuang Liu	director, 10 percent owner, officer: Chief Executive Officer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087

Goldenwell Biotech (Goldenwell Biotech) Headlines

No Headlines